Cd20-Tcb, A Novel T-Cell-Engaging Bispecific Antibody, Can Be Safely Combined With The Anti-Pd-L1 Antibody Atezolizumab In Relapsed Or Refractory B-Cell Non-Hodgkin LymphomaMartin Hutchings,Giuseppe Gritti,Anna Sureda,Maria Jose Terol,Martin Js Dyer,Gloria Iacoboni, William Townsend,Marina Bacac,Ann-Marie E Bröske,Natalie Dimier,Cristiano Ferlini,Abiraj Keelara,Angelika Lahr,Katharina Lechner,Tom Moore,Peter N Morcos,Anesh Panchal,Martin Weisser,Ciel De VriendtBLOOD（2019）引用 17|浏览25暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
